Pub Date : 2024-10-29DOI: 10.3390/pathogens13110938
Emil Robert Stoicescu, Laura Andreea Ghenciu, Roxana Iacob, Adina Iuliana Ardelean, Ecaterina Dăescu, Ovidiu Alin Hațegan, Diana Manolescu, Emanuela Tudorache, Casiana Boru, Mirabela Dima
Purpose: Cytomegalovirus (CMV) retinitis is a sight-threatening condition predominantly affecting immunocompromised individuals, such as those with Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS). We aimed to present an observational case report on CMV retinitis following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and to review the literature on the molecular and cellular changes in CMV and SARS-CoV-2 infections and how they may influence each other. Case Description: A 32-year-old man with a history of AIDS presented with decreased vision and ocular pain exacerbated by movement, beginning a day prior. Ocular examination revealed anterior uveitis, corneal endothelial edema, and retinal necrosis in the left eye. CMV retinitis was diagnosed based on positive serologic testing and a low cluster of differentiation 4 (CD4) count, with concurrent SARS-CoV-2 infection detected. Treatment included valganciclovir and topical agents, with a focus on managing CMV complications. This case highlights the potential role of SARS-CoV-2 in reactivating dormant CMV in severely immunocompromised individuals. We also discuss the implications of this interaction for immunocompromised patients, emphasizing the need for vigilant monitoring and personalized treatment strategies. Conclusions: Our case suggests that SARS-CoV-2 may trigger reactivation of CMV infection, leading to bilateral involvement in patients with low CD4 lymphocyte counts, which can result in severe visual impairment. The review discusses the molecular and cellular interactions between CMV and SARS-CoV-2, as well as risk factors, pathophysiology, and diagnostic methods for CMV retinitis, providing recommendations based on the literature findings.
{"title":"CMV Retinitis in the Context of SARS-CoV-2 Infection: A Case Study and Comprehensive Review of Viral Interactions.","authors":"Emil Robert Stoicescu, Laura Andreea Ghenciu, Roxana Iacob, Adina Iuliana Ardelean, Ecaterina Dăescu, Ovidiu Alin Hațegan, Diana Manolescu, Emanuela Tudorache, Casiana Boru, Mirabela Dima","doi":"10.3390/pathogens13110938","DOIUrl":"10.3390/pathogens13110938","url":null,"abstract":"<p><strong>Purpose: </strong>Cytomegalovirus (CMV) retinitis is a sight-threatening condition predominantly affecting immunocompromised individuals, such as those with Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS). We aimed to present an observational case report on CMV retinitis following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and to review the literature on the molecular and cellular changes in CMV and SARS-CoV-2 infections and how they may influence each other. <b>Case Description:</b> A 32-year-old man with a history of AIDS presented with decreased vision and ocular pain exacerbated by movement, beginning a day prior. Ocular examination revealed anterior uveitis, corneal endothelial edema, and retinal necrosis in the left eye. CMV retinitis was diagnosed based on positive serologic testing and a low cluster of differentiation 4 (CD4) count, with concurrent SARS-CoV-2 infection detected. Treatment included valganciclovir and topical agents, with a focus on managing CMV complications. This case highlights the potential role of SARS-CoV-2 in reactivating dormant CMV in severely immunocompromised individuals. We also discuss the implications of this interaction for immunocompromised patients, emphasizing the need for vigilant monitoring and personalized treatment strategies. <b>Conclusions:</b> Our case suggests that SARS-CoV-2 may trigger reactivation of CMV infection, leading to bilateral involvement in patients with low CD4 lymphocyte counts, which can result in severe visual impairment. The review discusses the molecular and cellular interactions between CMV and SARS-CoV-2, as well as risk factors, pathophysiology, and diagnostic methods for CMV retinitis, providing recommendations based on the literature findings.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597558/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-29DOI: 10.3390/pathogens13110941
Badriah Alkathiri, Subin Lee, KyuSung Ahn, So Youn Youn, Mi-Sun Yoo, Hyang-Sim Lee, Yun Sang Cho, Jaeyun Jung, Kwangwon Seo, Soochong Kim, Rika Umemiya-Shirafuji, Xuenan Xuan, Dongmi Kwak, SungShik Shin, Seung-Hun Lee
The objective of this study was to evaluate the diversity and prevalence of tick-borne protists in the Republic of Korea via DNA barcoding using 18S rRNA gene fragments and PCR. Between 2021 and 2022, questing ticks were collected using the flagging method, with a total of 13,375 ticks collected and pooled into 1003 samples. Of these, 50 tick pools were selected for DNA barcoding targeting the V4 and V9 regions of 18S rRNA using the MiSeq platform. A taxonomic analysis of the amplicon sequence variants identified three genera of protozoa, namely Hepatozoon canis, Theileria luwenshuni, and Gregarine sp. However, the number and abundance of protists detected were different depending on the primer sets, and T. gondii was not identified in DNA barcoding. Furthermore, conventional PCR confirmed the presence of H. canis, Toxoplasma gondii, T. luwenshuni, and Theileria sp. in the collected ticks. This study identified H. canis and T. gondii in Ixodes nipponensis for the first time. It demonstrated that the results of DNA barcoding using 18S rRNA gene fragments can vary depending on the primer sets and further optimization is required for library construction to identify tick-borne protists in ticks. Despite these limitations, the findings highlight the potential of DNA barcoding using 18S rRNA gene fragments for screening the diversity of tick-borne protists in ticks.
本研究旨在通过使用 18S rRNA 基因片段和 PCR 进行 DNA 条形编码,评估大韩民国蜱传原生动物的多样性和流行率。2021 年至 2022 年期间,采用标记法采集了蜱虫,共采集了 13,375 只蜱虫,汇集成 1003 个样本。在这些样本中,选择了 50 个蜱池,利用 MiSeq 平台针对 18S rRNA 的 V4 和 V9 区域进行 DNA 条形编码。对扩增子序列变异的分类分析确定了三个原生动物属,即犬肝吸虫属(Hepatozoon canis)、鲁文舒尼氏原生动物属(Theileria luwenshuni)和格雷加林原生动物属(Gregarine sp.)。 然而,不同引物组检测到的原生动物数量和丰度不同,而且在 DNA 条形编码中未发现淋病双球菌。此外,传统的聚合酶链式反应(PCR)证实了所采集的蜱虫中存在犬细小病毒、弓形虫、T. luwenshuni 和 Theileria sp.。这项研究首次在日本蜱中发现了犬细小病毒和弓形虫。该研究表明,使用 18S rRNA 基因片段进行 DNA 条形编码的结果会因引物组的不同而不同,因此需要进一步优化文库构建以鉴定蜱中的蜱传原生动物。尽管存在这些局限性,但研究结果凸显了利用 18S rRNA 基因片段进行 DNA 条形编码筛选蜱传原生动物多样性的潜力。
{"title":"DNA Barcoding Using 18S rRNA Gene Fragments for Identification of Tick-Borne Protists in Ticks in the Republic of Korea.","authors":"Badriah Alkathiri, Subin Lee, KyuSung Ahn, So Youn Youn, Mi-Sun Yoo, Hyang-Sim Lee, Yun Sang Cho, Jaeyun Jung, Kwangwon Seo, Soochong Kim, Rika Umemiya-Shirafuji, Xuenan Xuan, Dongmi Kwak, SungShik Shin, Seung-Hun Lee","doi":"10.3390/pathogens13110941","DOIUrl":"10.3390/pathogens13110941","url":null,"abstract":"<p><p>The objective of this study was to evaluate the diversity and prevalence of tick-borne protists in the Republic of Korea via DNA barcoding using 18S rRNA gene fragments and PCR. Between 2021 and 2022, questing ticks were collected using the flagging method, with a total of 13,375 ticks collected and pooled into 1003 samples. Of these, 50 tick pools were selected for DNA barcoding targeting the V4 and V9 regions of 18S rRNA using the MiSeq platform. A taxonomic analysis of the amplicon sequence variants identified three genera of protozoa, namely <i>Hepatozoon canis</i>, <i>Theileria luwenshuni</i>, and <i>Gregarine</i> sp. However, the number and abundance of protists detected were different depending on the primer sets, and <i>T. gondii</i> was not identified in DNA barcoding. Furthermore, conventional PCR confirmed the presence of <i>H. canis</i>, <i>Toxoplasma gondii</i>, <i>T. luwenshuni</i>, and <i>Theileria</i> sp. in the collected ticks. This study identified <i>H. canis</i> and <i>T. gondii</i> in <i>Ixodes nipponensis</i> for the first time. It demonstrated that the results of DNA barcoding using 18S rRNA gene fragments can vary depending on the primer sets and further optimization is required for library construction to identify tick-borne protists in ticks. Despite these limitations, the findings highlight the potential of DNA barcoding using 18S rRNA gene fragments for screening the diversity of tick-borne protists in ticks.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The bluetongue virus (BTV), transmitted by biting midges, poses a significant threat to livestock globally. This orbivirus induces bluetongue disease, leading to substantial economic losses in the agricultural sector. The current control measures have limitations, necessitating the development of novel, efficient vaccines. In this study, an immunoinformatics approach is employed to design a multi-epitope subunit vaccine for Ovis aries targeting six BTV serotypes. Focusing on the VP2 capsid protein, the vaccine incorporates B-cell, helper-T lymphocytes (HTL), and cytotoxic T-cell lymphocytes (CTL) epitopes. Molecular docking reveals stable interactions with TLR2 and TLR4 receptors, suggesting the stability of the complex, indicating the potential viability of the multi-epitope vaccine. The computational approach offers a rapid and tailored strategy for vaccine development, highlighting potential efficacy and safety against BTV outbreaks. This work contributes to understanding BTV and presents a promising avenue for effective control.
由咬蠓传播的蓝舌病病毒(BTV)对全球牲畜构成重大威胁。这种口蹄疫病毒会诱发蓝舌病,给农业部门造成巨大的经济损失。目前的控制措施存在局限性,因此有必要开发新型、高效的疫苗。本研究采用免疫信息学方法设计了一种针对六种蓝耳病血清型的多表位亚单位疫苗。该疫苗以 VP2 表位蛋白为重点,结合了 B 细胞、辅助 T 淋巴细胞 (HTL) 和细胞毒性 T 细胞淋巴细胞 (CTL) 表位。分子对接揭示了与 TLR2 和 TLR4 受体的稳定相互作用,表明了复合物的稳定性,也表明了多表位疫苗的潜在可行性。这种计算方法为疫苗开发提供了一种快速、量身定制的策略,突出了疫苗对乙型脑炎病毒爆发的潜在有效性和安全性。这项工作有助于人们了解 BTV,并为有效控制 BTV 提供了一条前景广阔的途径。
{"title":"In Silico Development of a Multi-Epitope Subunit Vaccine against Bluetongue Virus in <i>Ovis aries</i> Using Immunoinformatics.","authors":"Priyansha Raj Sinha, Shubhada R Hegde, Ruchika Mittal, Chikkamagaluru Chandrashekhar Jagat, Ullas Gowda, Rathna Chandrashekhar, Gayathri Muthaiah, Samer Shamshad, Mohammed Mudassar Chanda, Vishweshwar Ganji, Kalyani Putty, Divakar Hemadri","doi":"10.3390/pathogens13110944","DOIUrl":"10.3390/pathogens13110944","url":null,"abstract":"<p><p>The bluetongue virus (BTV), transmitted by biting midges, poses a significant threat to livestock globally. This orbivirus induces bluetongue disease, leading to substantial economic losses in the agricultural sector. The current control measures have limitations, necessitating the development of novel, efficient vaccines. In this study, an immunoinformatics approach is employed to design a multi-epitope subunit vaccine for <i>Ovis aries</i> targeting six BTV serotypes. Focusing on the VP2 capsid protein, the vaccine incorporates B-cell, helper-T lymphocytes (HTL), and cytotoxic T-cell lymphocytes (CTL) epitopes. Molecular docking reveals stable interactions with TLR2 and TLR4 receptors, suggesting the stability of the complex, indicating the potential viability of the multi-epitope vaccine. The computational approach offers a rapid and tailored strategy for vaccine development, highlighting potential efficacy and safety against BTV outbreaks. This work contributes to understanding BTV and presents a promising avenue for effective control.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597718/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-29DOI: 10.3390/pathogens13110942
Ava Mousavi, Karan N Thaker, James E Ackerman, Niccole Diaz, Rick Martin, Craig D Tipton, Nick Tallman, Lina Marcella Henao, Nima Nassiri, Jeffrey Veale, Anne Lenore Ackerman, Kymora B Scotland
(1) Background: Indwelling ureteral stents are commonly used urological devices to maintain ureteral patency, yet they have been associated with complications such as infections. Some studies have shown that bacteria adhere to and create an antimicrobial-resistant biofilm on stents. One factor that may impact biofilm formation is the original condition informing stent placement, such as kidney stones and renal allografts. Both kidney stones and renal allografts are independently associated with infection, yet the differential stent microbiomes of these populations remain poorly characterized. Our objective was to characterize these microbiomes in order to inform urological health practice and help prevent ureteral stent-associated infections. (2) Methods: Stents were collected from kidney stone and renal transplant recipients undergoing routine cystoscopic stent removal. Microbial DNA was extracted from stents and analyzed using 16S Next Generation Sequencing. Descriptive statistics, alpha diversity, and beta diversity methods were used for statistical analysis. (3) Results: The microbiome of ureteral stents in kidney stone and transplant patients is composed of unique species, each with different biofilm-forming abilities. (4) Conclusions: Our findings demonstrate that the microbiome of stents differs based on preceding condition. It is important to conduct future studies that explore this microbiome further to understand what type of stent-associated infection someone may develop based on their initial condition.
{"title":"Exploring Condition-Specific Variability in the Ureteral Stent Microbiome.","authors":"Ava Mousavi, Karan N Thaker, James E Ackerman, Niccole Diaz, Rick Martin, Craig D Tipton, Nick Tallman, Lina Marcella Henao, Nima Nassiri, Jeffrey Veale, Anne Lenore Ackerman, Kymora B Scotland","doi":"10.3390/pathogens13110942","DOIUrl":"10.3390/pathogens13110942","url":null,"abstract":"<p><p>(1) Background: Indwelling ureteral stents are commonly used urological devices to maintain ureteral patency, yet they have been associated with complications such as infections. Some studies have shown that bacteria adhere to and create an antimicrobial-resistant biofilm on stents. One factor that may impact biofilm formation is the original condition informing stent placement, such as kidney stones and renal allografts. Both kidney stones and renal allografts are independently associated with infection, yet the differential stent microbiomes of these populations remain poorly characterized. Our objective was to characterize these microbiomes in order to inform urological health practice and help prevent ureteral stent-associated infections. (2) Methods: Stents were collected from kidney stone and renal transplant recipients undergoing routine cystoscopic stent removal. Microbial DNA was extracted from stents and analyzed using 16S Next Generation Sequencing. Descriptive statistics, alpha diversity, and beta diversity methods were used for statistical analysis. (3) Results: The microbiome of ureteral stents in kidney stone and transplant patients is composed of unique species, each with different biofilm-forming abilities. (4) Conclusions: Our findings demonstrate that the microbiome of stents differs based on preceding condition. It is important to conduct future studies that explore this microbiome further to understand what type of stent-associated infection someone may develop based on their initial condition.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-29DOI: 10.3390/pathogens13110943
Cody F Price, John P Wood, Ibrahim Ismail, Simon Smith, Josh Hanson
Introduction: Patients receiving biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for rheumatological conditions are at an increased risk of serious, potentially life-threatening, infection. However, the incidence, aetiology, and clinical course of serious infection in patients receiving b/tsDMARDs in tropical settings are incompletely defined. Methods: We retrospectively reviewed all patients with rheumatoid arthritis receiving b/tsDMARDs between October 2012 and October 2021, at Cairns Hospital in tropical Australia. The incidence, aetiology, and clinical course of serious infections (those requiring admission to hospital or parenteral antibiotics) were determined. Results: 310 patients had 1468 patient years of b/tsDMARD therapy during the study period; 74/310 (24%) had 147 serious infections translating to an overall risk of 10.0 episodes of serious infection per 100 patient years. The respiratory tract (50/147, 34%) and skin (37/147, 25%) were the most frequently affected sites. A pathogen was identified in 59/147 (40%) episodes and was most commonly Staphylococcus aureus (24/147, 16%). Only 2/147 (1%) were confirmed "tropical infections": 1 case of Burkholderia pseudomallei and 1 case of mixed B. pseudomallei and community-acquired Acinetobacter baumannii infection. Overall, 13/147 (9%) episodes of serious infection required Intensive Care Unit admission (0.9 per 100-patient years of b/tsDMARD therapy) and 4/147 (3%) died from their infection (0.3 per 100-patient years of b/tsDMARD therapy). The burden of comorbidity and co-administration of prednisone were the strongest predictors of death or a requirement for ICU admission. Conclusions: The risk of serious infection in patients taking b/tsDMARDs in tropical Australia is higher than in temperate settings, but this is not explained by an increased incidence of traditional tropical pathogens.
{"title":"The Incidence, Aetiology and Clinical Course of Serious Infections Complicating Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Patients with Rheumatoid Arthritis in Tropical Australia.","authors":"Cody F Price, John P Wood, Ibrahim Ismail, Simon Smith, Josh Hanson","doi":"10.3390/pathogens13110943","DOIUrl":"10.3390/pathogens13110943","url":null,"abstract":"<p><p><b>Introduction</b>: Patients receiving biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for rheumatological conditions are at an increased risk of serious, potentially life-threatening, infection. However, the incidence, aetiology, and clinical course of serious infection in patients receiving b/tsDMARDs in tropical settings are incompletely defined. <b>Methods</b>: We retrospectively reviewed all patients with rheumatoid arthritis receiving b/tsDMARDs between October 2012 and October 2021, at Cairns Hospital in tropical Australia. The incidence, aetiology, and clinical course of serious infections (those requiring admission to hospital or parenteral antibiotics) were determined. <b>Results</b>: 310 patients had 1468 patient years of b/tsDMARD therapy during the study period; 74/310 (24%) had 147 serious infections translating to an overall risk of 10.0 episodes of serious infection per 100 patient years. The respiratory tract (50/147, 34%) and skin (37/147, 25%) were the most frequently affected sites. A pathogen was identified in 59/147 (40%) episodes and was most commonly <i>Staphylococcus aureus</i> (24/147, 16%). Only 2/147 (1%) were confirmed \"tropical infections\": 1 case of <i>Burkholderia pseudomallei</i> and 1 case of mixed <i>B. pseudomallei</i> and community-acquired <i>Acinetobacter baumannii</i> infection. Overall, 13/147 (9%) episodes of serious infection required Intensive Care Unit admission (0.9 per 100-patient years of b/tsDMARD therapy) and 4/147 (3%) died from their infection (0.3 per 100-patient years of b/tsDMARD therapy). The burden of comorbidity and co-administration of prednisone were the strongest predictors of death or a requirement for ICU admission. <b>Conclusions</b>: The risk of serious infection in patients taking b/tsDMARDs in tropical Australia is higher than in temperate settings, but this is not explained by an increased incidence of traditional tropical pathogens.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-29DOI: 10.3390/pathogens13110940
Francisco Epelde
Acute respiratory infections (ARIs) represent a significant global health burden, contributing to high morbidity and mortality rates, particularly in vulnerable populations. Traditional methods for diagnosing and tracking ARIs often face limitations in terms of speed, accuracy, and scalability. The advent of artificial intelligence (AI) has the potential to revolutionize these processes by enhancing early detection, precise diagnosis, and effective epidemiological tracking. This review explores the integration of AI in the epidemiology and diagnosis of ARIs, highlighting its capabilities, current applications, and future prospects. By examining recent advancements and existing studies, this paper provides a comprehensive understanding of how AI can improve ARI management, offering insights into its practical applications and the challenges that must be addressed to realize its full potential.
{"title":"How AI Could Help Us in the Epidemiology and Diagnosis of Acute Respiratory Infections?","authors":"Francisco Epelde","doi":"10.3390/pathogens13110940","DOIUrl":"10.3390/pathogens13110940","url":null,"abstract":"<p><p>Acute respiratory infections (ARIs) represent a significant global health burden, contributing to high morbidity and mortality rates, particularly in vulnerable populations. Traditional methods for diagnosing and tracking ARIs often face limitations in terms of speed, accuracy, and scalability. The advent of artificial intelligence (AI) has the potential to revolutionize these processes by enhancing early detection, precise diagnosis, and effective epidemiological tracking. This review explores the integration of AI in the epidemiology and diagnosis of ARIs, highlighting its capabilities, current applications, and future prospects. By examining recent advancements and existing studies, this paper provides a comprehensive understanding of how AI can improve ARI management, offering insights into its practical applications and the challenges that must be addressed to realize its full potential.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-29DOI: 10.3390/pathogens13110939
László Ózsvári, Krisztina Bárdos, Agata Moroz-Fik, Kinga Biernacka, Marcin Mickiewicz, Zofia Nowek, Carlos Eduardo Abril, Giuseppe Bertoni, Snorre Stuen, Saulius Petkevičius, Jarosław Kaba, Michał Czopowicz
In 2023, a molecular study was conducted on the Hungarian goat population to determine genotypes and subtypes of small ruminant lentiviruses (SRLV) infecting these herds. Ten goat herds seropositive for SRLV infection according to a serosurvey conducted earlier in Hungary were selected, and 135 adult goats (>1 year old) were blood sampled. The two-stage nested real-time PCR (nRT-PCR) was used to detect proviral DNA of SRLV and distinguish between two main viral genotypes (A and B). PCR products were submitted for Sanger dideoxy sequencing, and phylogenetic and molecular evolutionary analyses were conducted on the 200-250 bp-long proviral DNA sequences from the end of long terminal repeat (LTR) region and beginning of gag gene using the MEGA11 software. Reference strains included strains most identical to Hungarian sequences according to the Standard Nucleotide BLAST and prototypic strains for the relevant genotypes and subtypes. Proviral DNA of SRLV was detected in goats from all ten tested herds. A single SRLV genotype was detected in 6 herds-genotype A in three herds and B also in three herds. In four herds, mixed infection with genotypes A and B was confirmed. In total, 110/135 seropositive goats tested positive in the nRT-PCR (81.5%): 49/110 goats (44.5%) for genotype A, 54/110 goats (49.1%) for genotype B, and 7/110 goats (6.4%) for both genotypes. Hungarian sequences belonged to subtypes A1/A18, A2, and subtype B1. This is the first study which shows that Hungarian goats are infected by SRLV belonging to both genotypes A and B.
2023 年,对匈牙利山羊群体进行了一项分子研究,以确定感染这些羊群的小反刍兽疫病毒(SRLV)的基因型和亚型。根据匈牙利早些时候进行的血清调查,选择了 10 个 SRLV 感染血清阳性的山羊群,并对 135 只成年山羊(1 岁以上)进行了血液采样。采用两阶段巢式实时 PCR(nRT-PCR)检测 SRLV 的前病毒 DNA,并区分两种主要病毒基因型(A 型和 B 型)。PCR 产物被提交给 Sanger 双脱氧测序,并使用 MEGA11 软件对长末端重复(LTR)区末端和 gag 基因起始处的 200-250 bp 长的前病毒 DNA 序列进行了系统发育和分子进化分析。参考菌株包括根据标准核苷酸BLAST与匈牙利序列最相同的菌株,以及相关基因型和亚型的原型菌株。在所有十个检测羊群中都检测到了SRLV的病毒DNA。在 6 个羊群中检测到单一 SRLV 基因型,其中 3 个羊群检测到 A 基因型,3 个羊群检测到 B 基因型。在 4 个牧群中,证实了基因型 A 和 B 的混合感染。共有 110/135 头血清阳性山羊(81.5%)在 nRT-PCR 检测中呈阳性:49/110只山羊(44.5%)为基因型A,54/110只山羊(49.1%)为基因型B,7/110只山羊(6.4%)为两种基因型。匈牙利序列属于 A1/A18、A2 和 B1 亚型。这是首次研究表明匈牙利山羊同时感染了属于 A 和 B 基因型的 SRLV。
{"title":"First Molecular Characterization of Small Ruminant Lentiviruses in Hungarian Goat Population.","authors":"László Ózsvári, Krisztina Bárdos, Agata Moroz-Fik, Kinga Biernacka, Marcin Mickiewicz, Zofia Nowek, Carlos Eduardo Abril, Giuseppe Bertoni, Snorre Stuen, Saulius Petkevičius, Jarosław Kaba, Michał Czopowicz","doi":"10.3390/pathogens13110939","DOIUrl":"10.3390/pathogens13110939","url":null,"abstract":"<p><p>In 2023, a molecular study was conducted on the Hungarian goat population to determine genotypes and subtypes of small ruminant lentiviruses (SRLV) infecting these herds. Ten goat herds seropositive for SRLV infection according to a serosurvey conducted earlier in Hungary were selected, and 135 adult goats (>1 year old) were blood sampled. The two-stage nested real-time PCR (nRT-PCR) was used to detect proviral DNA of SRLV and distinguish between two main viral genotypes (A and B). PCR products were submitted for Sanger dideoxy sequencing, and phylogenetic and molecular evolutionary analyses were conducted on the 200-250 bp-long proviral DNA sequences from the end of long terminal repeat (LTR) region and beginning of <i>gag</i> gene using the MEGA11 software. Reference strains included strains most identical to Hungarian sequences according to the Standard Nucleotide BLAST and prototypic strains for the relevant genotypes and subtypes. Proviral DNA of SRLV was detected in goats from all ten tested herds. A single SRLV genotype was detected in 6 herds-genotype A in three herds and B also in three herds. In four herds, mixed infection with genotypes A and B was confirmed. In total, 110/135 seropositive goats tested positive in the nRT-PCR (81.5%): 49/110 goats (44.5%) for genotype A, 54/110 goats (49.1%) for genotype B, and 7/110 goats (6.4%) for both genotypes. Hungarian sequences belonged to subtypes A1/A18, A2, and subtype B1. This is the first study which shows that Hungarian goats are infected by SRLV belonging to both genotypes A and B.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-28DOI: 10.3390/pathogens13110937
Despina G Contopoulos-Ioannidis, Valerie Bonetti, Jose G Montoya
During the COVID-19 pandemic, prenatal care services were disrupted. We analyzed the trajectory slopes of cases of congenital toxoplasmosis (CT) and acute toxoplasmosis during pregnancy from 2019 to 2022 (to reflect the cases during the pandemic years 2020-2022) vs. 2000 to 2019, using data from the Remington Laboratory, the National Reference Center for Toxoplasmosis in the US. During the pandemic, there was a statistically significant upward trajectory in the yearly number of CT cases. Monitoring of this trend is needed.
{"title":"Increase in Congenital Toxoplasmosis During the COVID-19 Pandemic in the US.","authors":"Despina G Contopoulos-Ioannidis, Valerie Bonetti, Jose G Montoya","doi":"10.3390/pathogens13110937","DOIUrl":"10.3390/pathogens13110937","url":null,"abstract":"<p><p>During the COVID-19 pandemic, prenatal care services were disrupted. We analyzed the trajectory slopes of cases of congenital toxoplasmosis (CT) and acute toxoplasmosis during pregnancy from 2019 to 2022 (to reflect the cases during the pandemic years 2020-2022) vs. 2000 to 2019, using data from the Remington Laboratory, the National Reference Center for Toxoplasmosis in the US. During the pandemic, there was a statistically significant upward trajectory in the yearly number of CT cases. Monitoring of this trend is needed.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-28DOI: 10.3390/pathogens13110936
Assa Sittner, Elad Bar-David, Itai Glinert, Amir Ben-Shmuel, Josef Schlomovitz, Haim Levy, Shay Weiss
Anthrax is a fatal zoonotic disease caused by exposure to Bacillus anthracis spores. The CDC's guidelines divide anthrax treatment into three categories according to disease progression: post-exposure prophylaxis (PEP), systemic, and systemic with a suspicion of CNS infection. While the prognosis for PEP or the early treatment of systemic anthrax is very good, ingress of the bacteria into the CNS poses a substantial clinical challenge. Here, we use rabbits to test the efficacy of a combined treatment of meropenem and doxycycline, which is the first choice in the CDC recommendations for treating systemic patients with an indication of CNS infection. In addition, we test the efficacy of the first-generation cephalosporin, cefazolin, in treating different stages of the disease. We found that the combination of doxycycline and meropenem is highly effective in treating rabbits in our inhalation model. Cefazolin was efficient only for PEP or systemic-stage treatment and not for CNS-infected animals. Our findings support the CDC recommendation of using a combination of doxycycline and meropenem for systemic patients with or without indications of CNS infection. We found that cefazolin is a decent choice for PEP or early-stage systemic disease but recommend considering using this antibiotic only if all other options are not available.
炭疽是一种致命的人畜共患病,由接触炭疽杆菌孢子引起。疾病预防控制中心的指南根据病情发展将炭疽治疗分为三类:接触后预防(PEP)、全身性和全身性并怀疑中枢神经系统感染。虽然 PEP 或全身性炭疽早期治疗的预后很好,但细菌侵入中枢神经系统会带来巨大的临床挑战。在这里,我们用兔子来测试美罗培南和多西环素联合治疗的疗效,美罗培南和多西环素是美国疾病预防控制中心推荐的治疗有中枢神经系统感染迹象的全身性患者的首选药物。此外,我们还测试了第一代头孢菌素头孢唑啉在治疗疾病不同阶段的疗效。我们发现,在吸入模型中,多西环素和美罗培南联合用药对兔子的治疗非常有效。头孢唑啉仅对 PEP 或全身阶段的治疗有效,对中枢神经系统感染的动物无效。我们的研究结果支持疾病预防控制中心的建议,即对有或无中枢神经系统感染迹象的全身感染患者使用强力霉素和美罗培南联合疗法。我们发现头孢唑啉是 PEP 或早期全身性疾病的不错选择,但建议只有在没有其他选择的情况下才考虑使用这种抗生素。
{"title":"Closing the Gaps: Testing the Efficacy of Carbapenem and Cephalosporin Treatments of Late-Stage Anthrax in Rabbits.","authors":"Assa Sittner, Elad Bar-David, Itai Glinert, Amir Ben-Shmuel, Josef Schlomovitz, Haim Levy, Shay Weiss","doi":"10.3390/pathogens13110936","DOIUrl":"10.3390/pathogens13110936","url":null,"abstract":"<p><p>Anthrax is a fatal zoonotic disease caused by exposure to <i>Bacillus anthracis</i> spores. The CDC's guidelines divide anthrax treatment into three categories according to disease progression: post-exposure prophylaxis (PEP), systemic, and systemic with a suspicion of CNS infection. While the prognosis for PEP or the early treatment of systemic anthrax is very good, ingress of the bacteria into the CNS poses a substantial clinical challenge. Here, we use rabbits to test the efficacy of a combined treatment of meropenem and doxycycline, which is the first choice in the CDC recommendations for treating systemic patients with an indication of CNS infection. In addition, we test the efficacy of the first-generation cephalosporin, cefazolin, in treating different stages of the disease. We found that the combination of doxycycline and meropenem is highly effective in treating rabbits in our inhalation model. Cefazolin was efficient only for PEP or systemic-stage treatment and not for CNS-infected animals. Our findings support the CDC recommendation of using a combination of doxycycline and meropenem for systemic patients with or without indications of CNS infection. We found that cefazolin is a decent choice for PEP or early-stage systemic disease but recommend considering using this antibiotic only if all other options are not available.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597137/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-27DOI: 10.3390/pathogens13110935
Ji Woo Shin, Kang Eun Kim, Joon Sang Park, Min-Jeong Kim, Taek-Kyun Lee, Yu Jin Kim, Hyun-Jung Kim, Seon Min Kim, Seung Won Jung
Chlamys farreri is primarily cultivated in Japan, China, and South Korea. Although mass mortality of scallops has been occurring recently, likely caused by high temperatures or infectious diseases, the underlying cause remains unclear. Little is known regarding the viral diseases affecting them. Therefore, we explored DNA virus diversity in the mid-gut gland of C. farreri and compared it with that of seawater. C. farreri was cultivated at depths below 5 m from the sea surface in the coastal waters of South Korea and sampled from May to August 2018. Different DNA viral communities were observed in both C. farreri and seawater. In C. farreri, prevalent groups included Mimiviridae (7%), Poxviridae (6%), and Phycodnaviridae (5%). Conversely, the dominant groups in seawater were Autographiviridae (20%), Kyanoviridae (12%), and Zobellviridae (10%). We identified C. farreri-specific viral communities and potentially infectious viruses, such as Ostreid herpesvirus 1 and Abalone herpesvirus Victoria/AUS/2009. Furthermore, C. farreri acts as a reservoir for various viruses, which impact microbial community dynamics and disease transmission in marine ecosystems. Understanding these viral communities is crucial to protecting and restoring coastal ecosystems by highlighting their role in the transmission of potential avian- and bivalve-specific viruses.
Chlamys farreri 主要在日本、中国和韩国养殖。虽然最近扇贝大量死亡,很可能是高温或传染病造成的,但根本原因仍不清楚。人们对影响扇贝的病毒性疾病知之甚少。因此,我们对扇贝中肠腺中的 DNA 病毒多样性进行了研究,并与海水中的病毒多样性进行了比较。我们在韩国沿海水域距离海面 5 米以下的深度养殖了法氏鲟,并于 2018 年 5 月至 8 月期间进行了采样。在 C. farreri 和海水中观察到了不同的 DNA 病毒群落。在 C. farreri 中,主要的病毒群包括 Mimiviridae(7%)、Poxviridae(6%)和 Phycodnaviridae(5%)。相反,海水中的主要病毒群为 Autographiviridae(20%)、Kyanoviridae(12%)和 Zobellviridae(10%)。我们发现了 C. farreri 特有的病毒群落和潜在的传染性病毒,如 Ostreid herpesvirus 1 和 Abalone herpesvirus Victoria/AUS/2009。此外,C. farreri 还是各种病毒的贮藏库,影响着海洋生态系统中的微生物群落动态和疾病传播。了解这些病毒群落对保护和恢复沿海生态系统至关重要,因为它们在潜在的禽类和双壳贝类特异性病毒传播中发挥着重要作用。
{"title":"Metavirome Insights into the Diversity and Potential Pathogenic Infection of <i>Chlamys farreri</i> in the Coastal Seas of the Republic of Korea.","authors":"Ji Woo Shin, Kang Eun Kim, Joon Sang Park, Min-Jeong Kim, Taek-Kyun Lee, Yu Jin Kim, Hyun-Jung Kim, Seon Min Kim, Seung Won Jung","doi":"10.3390/pathogens13110935","DOIUrl":"10.3390/pathogens13110935","url":null,"abstract":"<p><p><i>Chlamys farreri</i> is primarily cultivated in Japan, China, and South Korea. Although mass mortality of scallops has been occurring recently, likely caused by high temperatures or infectious diseases, the underlying cause remains unclear. Little is known regarding the viral diseases affecting them. Therefore, we explored DNA virus diversity in the mid-gut gland of <i>C. farreri</i> and compared it with that of seawater. <i>C. farreri</i> was cultivated at depths below 5 m from the sea surface in the coastal waters of South Korea and sampled from May to August 2018. Different DNA viral communities were observed in both <i>C. farreri</i> and seawater. In <i>C. farreri</i>, prevalent groups included <i>Mimiviridae</i> (7%), <i>Poxviridae</i> (6%), and <i>Phycodnaviridae</i> (5%). Conversely, the dominant groups in seawater were <i>Autographiviridae</i> (20%), <i>Kyanoviridae</i> (12%), and <i>Zobellviridae</i> (10%). We identified <i>C. farreri</i>-specific viral communities and potentially infectious viruses, such as <i>Ostreid herpesvirus 1</i> and Abalone herpesvirus Victoria/AUS/2009. Furthermore, <i>C. farreri</i> acts as a reservoir for various viruses, which impact microbial community dynamics and disease transmission in marine ecosystems. Understanding these viral communities is crucial to protecting and restoring coastal ecosystems by highlighting their role in the transmission of potential avian- and bivalve-specific viruses.</p>","PeriodicalId":19758,"journal":{"name":"Pathogens","volume":"13 11","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142731453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}